Oricell Therapeutics
Health Care, Pharmaceutical, Product Research
Founded in 1/1/15
Shanghai, Shanghai, China
For Profit
About Oricell Therapeutics
OriCell Therapeutics develop drugs with good efficacy and affordable prices to satisfy the globally unmet clinical needs through innovations and strives to become the world-leading developer of novel drugs for tumor immunotherapy.
Company Metrics
- Employees: 101-250
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue:
- Total Funding: 165492876 USD
- Last Funding: 120000000 USD (Series B)
- Funding Status: Early Stage Venture
Technology Stack
Oricell Therapeutics actively uses None products in their tech stack.
Market Presence
Industries: Health Care, Pharmaceutical, Product Research
Headquarters: Shanghai, Shanghai, China